🔎 Trials Near Me

Pradžia › Minkštųjų audinių sarkoma › Ohio

Minkštųjų audinių sarkoma klinikiniai tyrimai Ohio

23 tyrimai dėl Minkštųjų audinių sarkoma ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Summa Health System - Barberton Campus, Barberton
  • ir dar 44
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Cleveland Clinic - Oncology Department, Cleveland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06760819

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

  • Ohio State University Comprehensive Cancer Center, Columbus
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06528769

DESTINY-PANTUMOUR04

  • Research Site, Canton
  • Research Site, Maumee
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07124000

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Renkami dalyviai1 fazė
Amžius nuo 12 iki 85 · Visoms lytims · Atnaujinta 2026-09-08 · NCT03715933

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

  • Nationwide Children's Hospital, Columbus
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 40 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07725380

Actinium Therapy for Late-stage Aggressive Sarcomas

  • Case Western, Cleveland
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07156565

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • The James Cancer Hospital and Solove Research Institute, Columbus
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT06263231

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT05210374

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Renkami dalyviai1/2 fazė
Iki 30 metų · Visoms lytims · Atnaujinta 2026-08-03 · NCT06239272

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

  • OSU James Hospital, Columbus
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-15 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • Ohio State University, Columbus
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-07-06 · NCT06710756

Integrated Cancer Repository for Cancer Research

  • Aultman Alliance Community Hospital, Alliance
  • Aultman Hospital, Canton
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • The Ohio State University Wexner Medical Center, Columbus
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-05-27 · NCT03093116

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

  • Ohio State University, Columbus
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-11 · NCT02677961

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Renkami dalyviai1/2 fazė
Amžius nuo 2 iki 30 · Visoms lytims · Atnaujinta 2026-02-03 · NCT05734066

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

  • Ohio State University Comprehensive Cancer Center, Columbus
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-02 · NCT06500065

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Cleveland Clinic, Cleveland
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-01-20 · NCT05366881

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-11 · NCT06943521

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
Renkami dalyviai2 fazė
18 Months – 40 Years · Visoms lytims · Atnaujinta 2025-08-12 · NCT05135975

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Renkami dalyviai1/2 fazė
Amžius 15 ir vyresni · Visoms lytims · Atnaujinta 2025-08-12 · NCT06298916

REtroperitoneal SArcoma Registry: an International Prospective Initiative

  • The Ohio State University, Columbus
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2019-02-12 · NCT03838718

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.